Prot# TMC114-C214: A Randomized, Controlled, Open-Label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV Versus LPV/RTV in Treatment-Experienced HIV-1 Infected Subjects

Project: Research project

Project Details

StatusFinished
Effective start/end date9/7/05 → 8/12/08

Funding

  • PPD Development (TMC114-C214 // TMC114-C214)
  • Tibotec Pharmaceuticals Ltd. (TMC114-C214 // TMC114-C214)